Matthias Köhler

Title: Matthias Köhler: Innovator in Blood Glucose Monitoring Systems

Introduction

Matthias Köhler is a notable inventor based in Laudenbach, GB. He has made significant contributions to the field of medical technology, particularly in the area of blood glucose monitoring systems. His innovative approach aims to improve the management of glucose metabolic disorders, enhancing the quality of life for individuals affected by these conditions.

Latest Patents

Köhler holds a patent for a "Blood glucose system having time synchronization." This invention provides a comprehensive solution for treating glucose metabolic disorders. The system includes a dosing device equipped with a counter for generating a count and memory for storing dose quantities and counts. Additionally, it features a blood glucose measuring device that has memory for storing blood glucose measurements and measurement times. A data processor is integrated into the system to receive data from both the dosing device and the blood glucose measuring device, converting counts to actual times. The data processor synchronizes the counts with the measurement times using a time standard, ensuring accurate monitoring and management of blood glucose levels.

Career Highlights

Matthias Köhler is currently employed at Roche Diabetes Care, Inc., a leading company in diabetes management solutions. His work at Roche has allowed him to focus on developing innovative technologies that assist patients in managing their diabetes effectively. His dedication to improving healthcare through technology is evident in his patent and ongoing projects.

Collaborations

Köhler collaborates with various professionals in the field, including his coworker Peter Blasberg. Together, they work on advancing diabetes care technologies, contributing to the overall mission of improving patient outcomes.

Conclusion

Matthias Köhler's contributions to blood glucose monitoring systems exemplify the impact of innovation in healthcare. His patented technology represents a significant advancement in the management of glucose metabolic disorders, showcasing his commitment to enhancing patient care.